Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudy Schreiber

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Plos One|November 14, 2013
Reversal learning and associative memory impairments in a BACHD rat model for Huntington diseaseYah-Se K Abada, Huu Phuc Nguyen, Bart Ellenbroek, et al.
Plos One|July 23, 2013
Assessment of motor function, sensory motor gating and recognition memory in a novel BACHD transgenic rat model for huntington diseaseYah-Se K Abada, Huu Phuc Nguyen, Rudy Schreiber, et al.
Trends in Pharmacological Sciences|November 10, 2019
Phosphodiesterase Type 4 Inhibition in CNS DiseasesArjan Blokland, Pim Heckman, Tim Vanmierlo, et al.
Drug Discovery Today|January 9, 2023
Rapid progress in neuroimaging technologies fuels central nervous system translational medicineLinghui Kong, Qian He, Qiu Li, et al.
Psychopharmacology|January 17, 2004
AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptorsMarja Van Kampen, Karin Selbach, Renate Schneider, et al.
European Journal of Pharmacology|September 27, 2012
The triple reuptake inhibitor DOV 216,303 induces long-lasting enhancement of brain reward activity as measured by intracranial self-stimulation in ratsJolanda Prins, Paul J Kenny, Ivo Doomernik, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 22, 2022
The diagnostic potential of fluid and imaging biomarkers in chronic traumatic encephalopathy (CTE)Anna Bergauer, Robin van Osch, Silke van Elferen, et al.
Psychopharmacology|March 29, 2022
How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational frameworkManon van den Berg, Igor Magaraggia, Rudy Schreiber, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 16, 2005
The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the ratCindy K J Lieben, Arjan Blokland, Ayhan Sik, et al.
Behavioural Brain Research|April 20, 2010
Effects of neurotensin-2 receptor deletion on sensorimotor gating and locomotor activityDavid Feifel, Zhen Pang, Zheng Pang, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Plos One|November 14, 2013
Reversal learning and associative memory impairments in a BACHD rat model for Huntington diseaseYah-Se K Abada, Huu Phuc Nguyen, Bart Ellenbroek, et al.
Plos One|July 23, 2013
Assessment of motor function, sensory motor gating and recognition memory in a novel BACHD transgenic rat model for huntington diseaseYah-Se K Abada, Huu Phuc Nguyen, Rudy Schreiber, et al.
Trends in Pharmacological Sciences|November 10, 2019
Phosphodiesterase Type 4 Inhibition in CNS DiseasesArjan Blokland, Pim Heckman, Tim Vanmierlo, et al.
Drug Discovery Today|January 9, 2023
Rapid progress in neuroimaging technologies fuels central nervous system translational medicineLinghui Kong, Qian He, Qiu Li, et al.
Psychopharmacology|January 17, 2004
AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptorsMarja Van Kampen, Karin Selbach, Renate Schneider, et al.
European Journal of Pharmacology|September 27, 2012
The triple reuptake inhibitor DOV 216,303 induces long-lasting enhancement of brain reward activity as measured by intracranial self-stimulation in ratsJolanda Prins, Paul J Kenny, Ivo Doomernik, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 22, 2022
The diagnostic potential of fluid and imaging biomarkers in chronic traumatic encephalopathy (CTE)Anna Bergauer, Robin van Osch, Silke van Elferen, et al.
Psychopharmacology|March 29, 2022
How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational frameworkManon van den Berg, Igor Magaraggia, Rudy Schreiber, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 16, 2005
The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the ratCindy K J Lieben, Arjan Blokland, Ayhan Sik, et al.
Behavioural Brain Research|April 20, 2010
Effects of neurotensin-2 receptor deletion on sensorimotor gating and locomotor activityDavid Feifel, Zhen Pang, Zheng Pang, et al.
Pageof 5